Before the first wave of the pandemic had tailed off and the second wave fears were not yet borne out, MassMutual Ventures’ Ryan Collins expressed a regret: he wished that that his Asia-focused venture capital firm had done more deals going into 2020, before the coronavirus first slowed business, and then changed the way it had to be done.
Collins, a partner at the Singapore-based branch of MMV, was addressing an In Vivo-hosted panel at the APACMed annual conference,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?